Evaluation of the Dose Response With Valsartan and Valsartan/Hydrochlorothiazide in Patients With Essential Hypertension

This patient data meta‐analysis included 9 randomized, double‐blind, placebo‐controlled trials (N=4278) of once‐daily valsartan 80, 160, or 320 mg or valsartan/hydrochlorothiazide 80/12.5, 160/12.5, 160/25, 320/12.5, or 320/25 mg given for 4 to 8 weeks. Efficacy variables included: (1) mean change i...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Hypertens (Greenwich)
Autori principali: Weir, Matthew R., Crikelair, Nora, Levy, Drew, Rocha, Ricardo, Kuturu, Venkatram, Glazer, Robert
Natura: Artigo
Lingua:Inglês
Pubblicazione: Le Jacq 2007
Soggetti:
Original Papers
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8110071/
https://ncbi.nlm.nih.gov/pubmed/17268215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1524-6175.2007.06415.x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi